Completed PHASE1 INTERVENTIONAL 1-arm NCT00488657

Improve Speech Using an In-the-ear Device in Parkinson's Disease (MJFFSpeech)

Treating Speech Disorders in Patients With Parkinson's Disease Using Altered Auditory Feedback

Sponsor: Michael J. Fox Foundation for Parkinson's Research

Conditions Dysarthria Parkinson's Disease

Updated 5 times since 2017 Last updated: Jan 17, 2013 Started: Jun 30, 2006 Primary completion: May 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00488657, this PHASE1 trial focuses on Dysarthria and Parkinson's Disease and remains completed. Sponsored by Michael J. Fox Foundation for Parkinson's Research, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Michael J. Fox Foundation for Parkinson's Research
Rush University Medical Center

Data source: Rush University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States